Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Failure to demonstrate mu-isoreceptors.

J D Rourke, J S Shaw

    Neuropeptides
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Naloxonazine and Mr2034 equally block morphine

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Effect of Baseline Performance and Age on Cognitive Training Improvements in Older Adults: A Qualitative Review.

    The journal of prevention of Alzheimer's disease·2020
    Same author

    Retrieval-induced forgetting in an eyewitness-memory paradigm.

    Psychonomic bulletin & review·2013
    Same author

    Lay Attitudes toward Genetic Testing for Susceptibility to Inherited Diseases.

    Journal of health psychology·2011
    Same author

    Infectious feline agranulocytosis.

    The American journal of pathology·2009
    Same author

    Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.

    Diabetic medicine : a journal of the British Diabetic Association·2007
    Same author

    Public eyewitness confidence ratings can differ from those held privately.

    Law and human behavior·2001
    Same journal

    The hemoglobin-derived peptide LVV-H7 attenuates select behavioral alterations in male spontaneously hypertensive rats.

    Neuropeptides·2026
    Same journal

    Neuropeptide Y in cancer metastasis and chemoresistance.

    Neuropeptides·2026
    Same journal

    Expression of the Galanin system in the human pancreas, pancreatitis, and pancreatic cancer: Association with nodal involvement and perineural invasion.

    Neuropeptides·2026
    Same journal

    PACAP promotes mitochondrial biogenesis in rat primary chondrocytes via the SIRT1/PGC-1α pathway.

    Neuropeptides·2026
    Same journal

    Galanin receptor 2: A multifunctional modulator in neurological diseases - Structure, mechanisms, and therapeutic prospects.

    Neuropeptides·2026
    Same journal

    Re-thinking neuropeptide therapeutics: What Neuropeptide Y and Galanin teach us about stress, resilience, and drug design.

    Neuropeptides·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Receptor studies

    Background:

    • Morphine is a potent opioid analgesic.
    • Opioid overdose can cause respiratory depression.
    • Selective antagonists for morphine's effects are sought.

    Purpose of the Study:

    • To investigate the selectivity of naloxonazine and Mr2034.
    • To determine if these antagonists block morphine's analgesic and respiratory effects distinctly.
    • To explore the receptor mechanisms underlying morphine's actions.

    Main Methods:

    • In vivo studies using animal models.
    • Administration of morphine and antagonists.
    • Assessment of analgesic and respiratory responses.

    Related Experiment Videos

    Main Results:

    • Naloxonazine and Mr2034 demonstrated equal efficacy.
    • Antagonists blocked both analgesic and respiratory depressant effects of morphine.
    • No selective antagonism was observed.

    Conclusions:

    • Morphine's analgesic and respiratory depressant effects share a common receptor.
    • Naloxonazine and Mr2034 are not selective antagonists for these effects.
    • Further research into opioid receptor subtypes may be warranted.